Tuteja Renu
Parasite Biology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
FEBS J. 2017 Aug;284(16):2592-2603. doi: 10.1111/febs.14109. Epub 2017 May 29.
Malaria is a human parasitic disease caused by infection from Plasmodium species, particularly Plasmodium falciparum. Each year millions of people are infected with malaria and large numbers of deaths result due to this deadly infection. P. falciparum contains 14 chromosomes, nearly 5400 genes and a multistage life cycle in humans and mosquitoes. The control of malaria is still a challenge as the parasite is continuously developing resistance to available antimalarial drugs and the mosquito vector is developing resistance to insecticides. The availability of P. falciparum genome has resulted in the identification of parasite-specific proteins that can be targeted without harmful effects to the human host. Toward this goal, we have been working on the identification and characterization of helicases in order to find parasite-specific helicases, which can be used as novel drug targets to tackle the rising problem of drug resistance. Helicases are ATP-dependent nucleic acid unwinding enzymes. The P. falciparum genome analysis depicts that it contains some parasite-specific helicases and homologs to most of the human helicases. Here, we present an overview of P. falciparum helicases and their importance in parasite growth and survival.
疟疾是一种由疟原虫属感染引起的人类寄生虫病,尤其是恶性疟原虫。每年有数百万人感染疟疾,大量死亡是由这种致命感染导致的。恶性疟原虫含有14条染色体、近5400个基因,在人类和蚊子体内具有多阶段生命周期。由于疟原虫对现有抗疟药物不断产生耐药性,且蚊子媒介对杀虫剂产生耐药性,疟疾的控制仍然是一项挑战。恶性疟原虫基因组的可用性使得能够鉴定出可作为靶点且对人类宿主无有害影响的寄生虫特异性蛋白质。为了实现这一目标,我们一直在致力于解旋酶的鉴定和表征,以找到寄生虫特异性解旋酶,它们可作为新型药物靶点来应对耐药性不断上升的问题。解旋酶是依赖ATP的核酸解旋酶。恶性疟原虫基因组分析表明,它含有一些寄生虫特异性解旋酶以及大多数人类解旋酶的同源物。在此,我们概述了恶性疟原虫解旋酶及其在寄生虫生长和存活中的重要性。